SCHEMBL24236137

SCHEMBL24236137

c1ccc2cc(-c3ccc(-c4c5ccccc5c(-c5cc6ccc7cccc8oc(c5)c6c78)c5ccccc45)cc3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
LPL P06858 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
CYP1A2 P05177 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
HCRTR1 O43613 1/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24236144 0.93 PGR (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24236104 0.90 CYP1A2 (0.40) ESR1ESR2CYP1A2ALDH1A1HPGD
SCHEMBL24236115 0.89 PGR (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL25975829 0.87 ALDH1A1 (0.39) CYP1A2ALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL24236173 0.86 GPR84 (0.39) ESR1ESR2LPLLIPGHSD17B1
SCHEMBL24236143 0.86 ENPP3 (0.38) ESR1ESR2CYP1A2ALDH1A1HPGD
SCHEMBL24236260 0.86 AHR (0.41) CYP1A2ALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24236316 0.84 MAPT (0.41) CYP1A2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL24236313 0.84 HSD17B1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24236130 0.84 ESR1 (0.36) ESR1ESR2LPLLIPGHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230255102-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-08-10 US disclosed
US-20230255102-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-08-10 US disclosed
US-20220037596-A1 PLURALITY OF LIGHT-EMITTING MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2022-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220037596-A1 PLURALITY OF LIGHT-EMITTING MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ELAVL1, EML4, NECTIN4 ESR1 280/4885ESR2 1087/4885LPL 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.